Structures by: Ayvazyan A.
Total: 8
1-Benzyl-6-phenylimino-5-(pyrrol-2-ylidene)hexahydropyrimidine-2,4-dione
C21H20N4O2
Acta Crystallographica Section E (2008) 64, 2 o483-o483
a=5.7844(12)Å b=10.378(2)Å c=15.595(3)Å
α=102.64(3)° β=93.32(3)° γ=102.45(3)°
7-Chloro-11a-phenyl-2,3,5,10,11,11a-hexahydro-1H- pyrrolo[2,1-c][1,4]benzodiazepine-5,11-dione
C18H15ClN2O2
Acta Crystallographica Section E (2008) 64, 3 o587
a=8.9749(18)Å b=9.2184(18)Å c=9.912(2)Å
α=86.90(3)° β=71.35(3)° γ=88.27(3)°
1-Benzyl-3-(2-furylmethyl)-1,2,3,4,5,6- hexahydrospiro[benzo[<i>h</i>]quinazoline-5,1'-cyclohexane]-2,4-dione
C29H28N2O3
Acta Crystallographica Section E (2008) 64, 4 o748
a=10.615(2)Å b=11.472(2)Å c=11.923(2)Å
α=109.90(2)° β=97.95(2)° γ=115.41(2)°
Ethyl 1-benzoyl-4-chloro-2-phenylprolinate
C20H20ClNO3
Acta Crystallographica Section E (2007) 63, 10 o3967-o3967
a=9.4241(19)Å b=10.073(2)Å c=19.849(4)Å
α=90.00° β=102.52(3)° γ=90.00°
1-(4-methylphenyl)-5-oxo-2-phenylpyrrolidine-2-carboxamide --methanol (1/1)
C18H18N2O2,CH4O
Acta Crystallographica Section E (2007) 63, 10 o4017-o4017
a=7.9421(16)Å b=20.761(4)Å c=10.403(2)Å
α=90.00° β=94.47(3)° γ=90.00°
1-(4-Bromobenzoyl)-2-phenylpyrrolidine-2-carboxamide
C18H17BrN2O2
Acta Crystallographica Section E (2008) 64, 3 o580
a=9.5707(19)Å b=13.738(3)Å c=13.302(3)Å
α=90.00° β=96.99(2)° γ=90.00°
[(4-Dimethylamino-2-methyl-5-phenylfuran-3-yl)methyl]diethylmethylazanium iodide
C19H29N2O,I
Acta Crystallographica Section E (2011) 67, 10 o2693
a=17.905(4)Å b=7.2458(14)Å c=15.732(3)Å
α=90.00° β=94.84(3)° γ=90.00°
2-(1,3,7,9-Tetramethyl-2,4,6,8-tetraoxo-1,2,3,4,6,7,8,9-octahydropyrido[2,3-<i>d</i>:6,5-<i>d</i>']dipyrimidin-5-yl)benzamide <i>N</i>,<i>N</i>-dimethylformamide hemisolvate
2(C20H18N6O5),C3H7NO
Acta Crystallographica Section E (2014) 70, 10 213-215
a=26.173(4)Å b=26.173(4)Å c=12.434(3)Å
α=90° β=90° γ=90°